Modified form of chemotherapy before and after surgery enhances survival in pancreatic cancer patients

FHS
June 20, 2024
6:31 pm

Patients with pancreatic cancer who received chemotherapy both before and after surgery experienced longer survival rates than would be expected from surgery followed by chemotherapy, according to a new study from researchers at Yale Cancer Center (YCC) and Yale School of Medicine.

Emergency Physicians Group Votes to Bar Use of the Term ‘Excited Delirium’

The American College of Emergency Physicians (ACEP) voted to stop using the term “excited delirium” when referring to patients with hyperactive delirium, joining a host

October 24, 2023

Organon Bolsters Research & Development Expertise with Two Leadership Appointments

Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, today announced the appointment of Juan Camilo Arjona Ferreira, M.D., as Chief

September 7, 2023

Study suggests CT imaging with automated AI system predicts EGFR genotype, identifying mutation status cost-effectively and non-invasively

Researchers developed an artificial intelligence (AI)-based predictive system (AIPS) model for the early detection of lung cancer by combining radiological, clinical, and genetic data.

February 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.